NanoBioFaces group perform cutting edge research at the nano-bio interface to identify opportunities and risks of nanomaterials at early stage of development, in a multidisciplinary environment covering chemistry, biochemistry, molecular biology, toxicology, risk assessment and regulatory science. High-impact testing platform for more tailored risk assessment and decision making is based on advanced biochemistry, immunology, toxicology, molecular and cell biology facilities.